Drug profile · INN
gatifloxacin
GATIFLOXACIN
gatifloxacin (GATIFLOXACIN) is a dna gyrase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — gatifloxacin
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 4
- Programs
- 1
- Data quality
- 0.84
Quick answer
gatifloxacin (GATIFLOXACIN) is a dna gyrase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA gyrase inhibitor
Primary target: DNA gyrase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is gatifloxacin?
gatifloxacin (GATIFLOXACIN) is a dna gyrase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for gatifloxacin?
GATIFLOXACIN is a marketed brand name for gatifloxacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gatifloxacin?
gatifloxacin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.